DUSTIN GOTTFELD: Open Payments
NPI 1861036964 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,072 in 118 payments from 20 companies in 2025. Trend: 2023 $603 · 2024 $4,921 · 2025 $3,072
Food & beverage: $2,988Education: $84
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 23 | $726 |
| ABBVIE INC. | 30 | $652 |
| Janssen Biotech, Inc. | 13 | $360 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $305 |
| Ardelyx, Inc. | 6 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $136 |
| Boston Scientific Corporation | 1 | $114 |
| Phathom Pharmaceuticals, Inc. | 5 | $101 |
| Aimmune Therapeutics, Inc. | 1 | $91 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
Products named: REZDIFFRA, TREMFYA, XIFAXAN, RINVOQ, SKYRIZI, LINZESS, IBSRELA, CREON.
Industry payments across CA — which companies pay providers there.
